Sanofi-Aventis' H5N1 bird flu vaccine has won approval from the US
Food and Drug Administration (FDA) as a limited protection measure
in case of a pandemic.
Pharmaceutical companies manufacturing vaccines to protect against
avian flu outbreaks will be protected from product liability claims
according to new regulations announced by the US Department of
Health and Human Services (HHS).
Biotechnology firm Gilead has acquired Raylo Chemicals, a Canadian
production unit of active pharmaceutical ingredients (APIs) and
advanced intermediates, from Degussa for €115m, seeking to bring
more manufacturing capacity and expertise...
As worldwide fears of a bird flu pandemic escalates, US border control are fighting an influx of fake Tamiflu products being imported into the country. Such products have been surfacing across the country as the global Tamiflu shortage has led to a scramble...
Concern over the threat of a new flu pandemic is hiking demand for
Roche's Tamiflu >(oseltamivir phosphate) product to the extent
that the firm needs to build another production plant, reports
Phil Taylor.